Advanced search
Publication Cover
Medical Mycology Volume 50, 2012 - Issue 1
Submit an article Journal homepage
208
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Voriconazole-associated severe hyponatremia

Kye-Hyung Kim *Department of Internal Medicine;Department of Internal Medicine, School of Medicine, Pusan National University, Busan, Republic of Korea
,
Seunghwan LeeDepartment of Pharmacology, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Shinwon Lee *Department of Internal Medicine;Division of Infectious Disease, Fatima hospital, Daegu, Republic of Korea
,
Na Ra Yun *Department of Internal Medicine;Department of Internal Medicine, School of Medicine, Chosun University, Gwangju, Republic of Korea
,
Nam Joong Kim *Department of Internal Medicine
,
Kyung-Sang YuDepartment of Pharmacology, Seoul National University College of Medicine, Seoul, Republic of Korea
,
In-Jin JangDepartment of Pharmacology, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Wan Beom Park *Department of Internal MedicineCorrespondence[email protected]
&
Myoung-Don Oh *Department of Internal Medicine
 show all
Pages 103-105 | Received 15 Dec 2010, Accepted 08 May 2011, Published online: 15 Jun 2011

References

  • Walsh TJ, Anaissie EJ, Denning DW, . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327–360.
  • Boyd AE, Modi S, Howard SJ, . Adverse reactions to voriconazole. Clin Infect Dis 2004; 39: 1241–1244.
  • Isobe K, Muraoka S, Sugino K, . Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy. Nihon Kokyuki Gakkai Zasshi 2007; 45: 489–493.
  • Teranishi J, Nagatoya K, Kakita T, . Voriconazole-associated salt-losing nephropathy. Clin Exp Nephrol 2010; 14: 377–380.
  • Naranjo CA, Busto U, Sellers EM, . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–245.
  • Jeong S, Nguyen PD, Desta Z. Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A. Antimicrob Agents Chemother 2009; 53: 541–551.
  • Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 356: 2064–2072.
  • Lewis RE. What is the ‘therapeutic range’ for voriconazole? Clin Infect Dis 2008; 46: 212–214.
  • Bruggemann RJ, Donnelly JP, Aarnoutse RE, . Therapeutic drug monitoring of voriconazole. Ther Drug Monit 2008; 30: 403–411.
  • Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/ pharmacodynamic profile of voriconazole. Clin Pharmacokinet 2006; 45: 649–663.
  • Smith J, Andes D. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther Drug Monit 2008; 30: 167–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.